Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker

All categories

DBCAT003515Therapeutic category

A DrugBank category of 1 drug. 1 of them is approved.

Drugs: Ivabradine

What you can answer from here — as of October 25, 2017

1DrugEach linked to its full drug card

Listed above

2Drug targetsEvery drug–target pair in the class, with bond type

709Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account